InterCure Ltd (INCR) has fallen Thursday morning, with the stock declining -1.58% in pre-market trading to 2.49. INCR's short-term technical score of 75 indicates that the stock has traded more bullishly over the last month than 75% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 93 out of 146 industries, the stock ranks higher than 81% of stocks. InterCure Ltd has risen 32.46% over the past month, closing at $1.95 on February 29. During this period of time, the stock fell as low as $1.75 and as high as $2.61. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
INCR has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on INCR!